Previous 10 | Next 10 |
Akebia Therapeutics (NASDAQ: AKBA ) -69% after vadadustat misses safety endpoints in late-stage studies in CKD anemia. More news on: Akebia Therapeutics, Inc., Zuora, Inc., PagerDuty, Inc., Stocks on the move, , Read more ...
Gainers: Corcept Therapeutics (NASDAQ: CORT ) +35% . More news on: Corcept Therapeutics Incorporated, Vera Bradley, Inc., NanoViricides, Inc., Stocks on the move, , Read more ...
Aditx Therapeutics (NASDAQ: ADTX ) stumbles ~20% in pre-market, on announcing it has priced follow-on public offering of 2.4M units at $4/unit; each unit will separate into one share of common stock, one Series A-1 Warrant, and one Series B-1 Warrant. More news on: ADi...
LOMA LINDA, CA, Sept. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune mo...
ADiTx Therapeutics (NASDAQ: ADTX ) -16% . More news on: ADiTx Therapeutics, Inc., Plus Therapeutics, Inc., Aptorum Group Limited, Stocks on the move, , Read more ...
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...
Gainers: Aimmune Therapeutics (NASDAQ: AIMT ) +171% . More news on: Aimmune Therapeutics, Inc., Akcea Therapeutics, Inc., Genworth Financial, Inc., Stocks on the move, Read more ...
Presentation on Thursday, September 3rd at 12:20 PM ET LOS ANGELES, CA / ACCESSWIRE / August 27, 2020 / Aditx Therapeutics, Inc. (Aditxt) (the "Company") (NASDAQ:ADTX), a life sciences company developing biotechnologies focused on improving the health of the immune system through immune...
Mr. Kiaie has Extensive Experience in Medical Device Product Development Loma Linda, CA, Aug. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specifically foc...
If Granted, EUA would Enable the Commercial Launch of AditxtScore for COVID-19 LOMA LINDA, CA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE ‒ Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnol...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...